Noticias de NVS_US
Noticias del mercado
Últimas noticias sobre NVS_US — 494 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Novartis stock climbed on September 1, 2026 after positive late-stage trial results for its multiple
Notably, Novartis revealed that remibrutinib wasn’t associated with the kind of liver-related side effects other BTK inhibitors like it have encountered.
Novartis reported Phase 3 REMODEL trial results showing remibrutinib reduced relapse rates and MRI lesions in relapsing multiple sclerosis.
The shares of the Swiss pharmaceutical corporation Novartis AG jumped by more than 4.5% on Tuesday, after the company reported positive results in the phase III trial of its drug candidate for the tre...
Novartis Halts Autoimmune Cell Therapy Trials After Patient Deaths
Novartis stock is digesting news that the company has halted several autoimmune cell therapy studies
Página 3 de 25